1. Yu KH, Bae HJ, Kwon SU, Kang DW, Hong KS, Lee YS, Rha JH, Koo JS, Kim JS, Kim JH, Lee JH, Cho SJ, Hwang SH, Jung S, Han MK, Cho KH, Kim BC, Shin DJ, Chang DI, Park JH, Kim EG, Jung DS, Ahn MY, Lee DH, Park KW, Kim YJ, Lee KY, Heo JH, Kim SH, Lee KH, Chung CS, Cha JK, Lee JH, Uhm KY, Lee BC, Roh JK. Analysis of 10,811 cases with acute ischemic stroke from Korean stroke registry: Hospital-Based Multicenter Prospective Registration Study. J Korean Neurol Assoc 2006;24:535-543.
2. Suh DC, Lee SH, Kim KR, Park ST, Lim SM, Kim SJ, Choi CG, Lee HK. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003;24:239-244.
3. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158-159.
4. Ji KY, Ahn JY, Chung YS, Kim OJ, Choi SW, Lee BH. Stent-assisted angioplasty for symptomatic middle cerebral artery stenosis: short-term arteriographic and clinical outcome. J Korean Neurosurg Soc 2003;34:96-103.
5. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.
6. Suh DC, Kim SJ, Lee DH, Kim W, Choi CG, Lee JH, Kim HJ, Kwon SU, Kim JS. Outcome of endovascular treatment in symptomatic intracranial vascular stenosis. Korean J Radiol 2005;6:1-7.
7. Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830-834.
8. Suh DC, Kim JK, Choi JW, Choi BS, Pyun HW, Choi YJ, Kim MH, Yang HR, Ha HI, Kim SJ, Lee DH, Choi CG, Hahm KD, Kim JS. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781-785.
9. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M. NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-1524.
10. Fiorella DJ, Turk AS, Levy EI, Pride GL Jr, Woo HH, Albuquerque FC, Welch BG, Niemann DB, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. U.S. Wingspan Registry: 12-month follow-up results. Stroke 2011;42:1976-1981.
11. Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke 2011;42:1971-1975.
12. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ. SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003.
13. Abou-Chebl A, Steinmetz H. Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine. Stroke 2012;43:616-620.
14. Park KY. Critical appraisal of SAMMPRIS Study. Korean J Stroke 2012;14:55-56.
15. Bae HJ, Yoon BW, Kang DW, Koo JS, Lee SH, Kim KB, Lee J, Roh JK. Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006;21:112-119.
16. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, Huh K. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005;65:296-298.
17. Ryu CW, Jahng GH, Kim EJ, Choi WS, Yang DM. High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis 2009;27:433-442.
18. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112-1120.
19. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998;29:1389-1392.
20. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
21. Kwon SU, Hong KS, Kang DW, Park JM, Lee JH, Cho YJ, Yu KH, Koo JS, Wong KS, Lee SH, Lee KB, Kim DE, Jeong SW, Bae HJ, Lee BC, Han MK, Rha JH, Kim HY, Mok VC, Lee YS, Kim GM, Suwanwela NC, Yun SC, Nah HW, Kim JS. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011;42:2883-2890.
22. Lee TH, Choi CH, Park KP, Sung SM, Lee SW, Lee BH, Kim DH, Kim HJ, Kim CW, Kim S. Techniques for intracranial stent navigation in patients with tortuous vessels. AJNR Am J Neuroradiol 2005;26:1375-1380.
23. Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415-423.
24. Rho GJ, Shin WR, Kong TS, Kim MS, Lee CJ, Lee BH. Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease. J Korean Neurosurg Soc 2011;50:40-44.
25. Seo KD, Lee KO, Kim DJ, Lee KY. Rescue use of tirofiban for acute carotid in-stent thrombosis. Yonsei Med J 2008;49:163-166.
26. Brus-Ramer M, Starke RM, Komotar RJ, Meyers PM. Radiographic evidence of cerebral hyperperfusion and reversal following angioplasty and stenting of intracranial carotid and middle cerebral artery stenosis: case report and review of the literature. J Neuroimaging 2010;20:280-283.
27. Suh DC, Sung KB, Cho YS, Choi CG, Lee HK, Lee JH, Kim JS, Lee MC. Transluminal angioplasty for middle cerebral artery stenosis in patients with acute ischemic stroke. AJNR Am J Neuroradiol 1999;20:553-558.
28. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, Kim TS, Kim JK, Kang HK. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005;237:620-626.
29. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016-1020.
30. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008;39:1766-1769.
31. Moon CM, Chun SH, Kim JB, Jung JH, Ko YG, Kim SM, Kim DI, Lee SH, Shim WH. Endovascular drug-coated stenting of basilar artery stenosis: a case report and literature review. Korean Circ J 2004;34:913-918.
32. Huang Q, Hong B, Xu Y, Liu J. Very late thrombosis in a patient with a drug-eluting stent for intracranial atherosclerotic stenosis. J Clin Neurosci 2009;16:1631-1633.
33. Mocco J, Darkhabani Z, Levy EI. Pharos neurovascular intracranial stent: elective use for a symptomatic stenosis refractory to medical therapy. Catheter Cardiovasc Interv 2009;74:642-646.
34. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531-1537.
35. Lee DH, Morsi H, Diaz O, Arat A, Mawad ME. The Wingspan stent system for the treatment of intracranial atherosclerotic stenoses: a single center experience. Neurointervention 2009;4:87-93.
36. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:1868-1872.
37. Zaidat OO. Periprocedural management of patients with endovascular treatment of intracranial atherosclerotic disease. J Neuroimaging 2009;19:Suppl 1. 35S-38S.